
Optimize Levodopa with ONGENTYS1,2
ONGENTYS® (opicapone) capsules is the early levodopa/carbidopa partner that may allow patients to stay on their current levodopa dose
ONGENTYS® (opicapone) capsules is the early levodopa/carbidopa partner that may allow patients to stay on their current levodopa dose
Chapter 1
Hear Dr. Hauser discuss his approach to treating Parkinson’s disease (PD) and what he considers when choosing an effective therapy.
Chapter 2
Watch 2 specialists discuss the benefits of once-daily ONGENTYS and what its efficacy and safety data could mean for patients with PD.
Chapter 3
Two specialists share their insights on prescribing ONGENTYS, focusing on identifying the appropriate patient type for this once-daily COMT inhibitor.
Increased Levodopa Exposure
ONGENTYS increased levodopa trough concentrations and overall levodopa exposure.1-3
Learn More
Earlier Use Subgroups
In the earlier stages of levodopa treatment and disease state, ONGENTYS reduced off time.4,5
SEE THE DATA
Patient Support
Prescribe ONGENTYS with confidence for patients with PD experiencing off episodes.
EXPLORE SUPPORT
ONGENTYS® (opicapone) capsules is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.
ONGENTYS is contraindicated in patients with: